Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| ARUP Laboratories, |
RCV005229809 | SCV005878469 | likely benign | not provided | 2024-08-05 | criteria provided, single submitter | clinical testing | The HBA1 c.55G>C; p.Gly19Arg variant (Hb Handsworth, also known as Gly18Arg when numbered from the mature protein, rs34504387, ClinVar Variation ID 15736, HbVar ID: 22) has been reported as a stable hemoglobin and identified in the HBA2 gene of heterozygous individuals without clinically significant symptoms (Al Zadjali 2014, Griffiths 1977, see HbVar database and references therein). However, it has not been previously described in the literature in the HBA1 gene, and the phenotype of this variant in the presence of other alpha globin variants is unknown. This HBA1 variant is absent from the Genome Aggregation Database (v2.1.1), indicating it is not a common polymorphism. Computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.462). Based on available information, this variant is considered to be likely benign. References: Link to HbVar database: https://globin.bx.psu.edu/hbvar/menu.html Al Zadjali S et al. Potential pitfalls in the diagnosis of Hb Handsworth in areas with high prevalence of HbS. Int J Lab Hematol. 2014 Aug;36(4):488-92. PMID: 24165563. Griffiths KD et al. Haemoglobin Handsworth alpha 18 (A16) glycine leads to arginne. FEBS Lett. 1977 Mar 15;75(1):93-5. PMID: 852596. |
| OMIM | RCV000017037 | SCV000037309 | other | HEMOGLOBIN HANDSWORTH | 2016-07-20 | no assertion criteria provided | literature only |